These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 8658786

  • 1. Changes of bone metabolism indices in patients receiving immunosuppressive therapy including low doses of steroids after renal transplantation.
    Yun YS, Kim BJ, Hong SP, Lee TW, Lim CG, Kim MJ.
    Transplant Proc; 1996 Jun; 28(3):1561-4. PubMed ID: 8658786
    [No Abstract] [Full Text] [Related]

  • 2. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.
    Goffin E, Devogelaer JP, Lalaoui A, Depresseux G, De Naeyer P, Squifflet JP, Pirson Y, van Ypersele de Strihou C.
    Transpl Int; 2002 Mar; 15(2-3):73-80. PubMed ID: 11935163
    [Abstract] [Full Text] [Related]

  • 3. Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation.
    Giannini S, D'Angelo A, Carraro G, Antonello A, Di Landro D, Marchini F, Plebani M, Zaninotto M, Rigotti P, Sartori L, Crepaldi G.
    Clin Nephrol; 2001 Nov; 56(5):353-63. PubMed ID: 11758005
    [Abstract] [Full Text] [Related]

  • 4. Changes in bone mineral density and selected metabolic parameters over 24 months following renal transplantation.
    Al-Gabri S, Zadrazil J, Krejcí K, Horák P, Bachleda P.
    Transplant Proc; 2005 Mar; 37(2):1014-9. PubMed ID: 15848609
    [Abstract] [Full Text] [Related]

  • 5. Bone mineral content in cyclosporine-treated renal transplant patients.
    Massari PU, Garay G, Ulla MR.
    Transplant Proc; 1994 Oct; 26(5):2646-8. PubMed ID: 7940826
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients.
    Tałałaj M, Gradowska L, Marcinowska-Suchowierska E, Durlik M, Gaciong Z, Lao M.
    Transplant Proc; 1996 Dec; 28(6):3485-7. PubMed ID: 8962355
    [No Abstract] [Full Text] [Related]

  • 9. Reduction of immunosuppressive therapy after renal transplantation: a randomized study.
    Heering P, Westhoff A, Ivens K, Kutkuhn B, Grabensee B.
    Transplant Proc; 1994 Oct; 26(5):2530-2. PubMed ID: 7940778
    [No Abstract] [Full Text] [Related]

  • 10. Factors involved in the loss of bone mineral density after renal transplantation.
    Torregrosa JV, Campistol JM, Montesinos M, Fenollosa B, Pons F, Martinez de Osaba MJ, Oppenheimer F.
    Transplant Proc; 1995 Aug; 27(4):2224-5. PubMed ID: 7652782
    [No Abstract] [Full Text] [Related]

  • 11. Structural skeletal impairment induced by immunosuppressive therapy in rats: cyclosporine A vs tacrolimus.
    Abdelhadi M, Ericzon BG, Hultenby K, Sjöden G, Reinholt FP, Nordenström J.
    Transpl Int; 2002 Apr; 15(4):180-7. PubMed ID: 11976740
    [Abstract] [Full Text] [Related]

  • 12. Pentoxifylline as an adjunct to cyclosporine-based immunosuppression does not improve the outcome of renal transplantation.
    Königsrainer A, Aichberger C, Riedmann B, Steurer W, Ofner D, Margreiter R.
    Transplant Proc; 1995 Feb; 27(1):1062-3. PubMed ID: 7878805
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effects of tacrolimus vs cyclosporin-A on bone metabolism after kidney transplantation: a cross-sectional study in 28 patients].
    Albano L, Casez JP, Bekri S, Gigante M, Champenois I, Cassuto-Viguier E, Jaeger P.
    Nephrol Ther; 2005 May; 1(2):115-20. PubMed ID: 16895674
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of tolerability, safety, and efficacy of cyclosporine microemulsion in renal transplant recipients.
    Gracida C, Melchor JL, Miranda ME, Bartolano C.
    Transplant Proc; 1996 Aug; 28(4):2171-3. PubMed ID: 8769191
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.